4.7 Article

Tuberculosis preventive treatment among individuals with inactive tuberculosis suggested by untreated radiographic abnormalities: a community-based randomized controlled trial

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Respiratory System

Protective efficacy of 6-week regimen for latent tuberculosis infection treatment in rural China: 5-year follow-up of a randomised controlled trial

Henan Xin et al.

Summary: The study suggests that the 6-week twice-weekly regimen of rifapentine plus isoniazid for LTBI treatment could be an optional tool for TB control in the Chinese population.

EUROPEAN RESPIRATORY JOURNAL (2022)

Article Infectious Diseases

Trends in the disease burden of HBV and HCV infection in China from 1990-2019

Tingting Yue et al.

Summary: The disease burden of HBV and HCV infection has decreased in China over the past 30 years, but HBV incidences remain high, especially in men. Effective management of HBV and HCV infections is still needed for high-risk populations.

INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2022)

Article Medicine, General & Internal

One Month of Rifapentine plus Isoniazid to Prevent HIV-Related Tuberculosis

S. Swindells et al.

NEW ENGLAND JOURNAL OF MEDICINE (2019)

Article Medicine, General & Internal

Four Months of Rifampin or Nine Months of Isoniazid for Latent Tuberculosis in Adults

D. Menzies et al.

NEW ENGLAND JOURNAL OF MEDICINE (2018)

Article Respiratory System

Treatment of latent infection with Mycobacterium tuberculosis: update 2010

C. C. Leung et al.

EUROPEAN RESPIRATORY JOURNAL (2011)

Article Medicine, General & Internal

Three Months of Rifapentine and Isoniazid for Latent Tuberculosis Infection

Timothy R. Sterling et al.

NEW ENGLAND JOURNAL OF MEDICINE (2011)